IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes the most prevalent dementia in the elderly people. Obesity and insulin resistance, which may cause major health problems <i>per se</i>, are risk factors for AD, and cytokines such as interleukin-6 (IL-6) have a role in...
Main Authors: | Anna Escrig, Amalia Molinero, Brenda Méndez, Mercedes Giralt, Gemma Comes, Paula Sanchis, Olaya Fernández-Gayol, Lydia Giménez-Llort, Christoph Becker-Pauly, Stefan Rose-John, Juan Hidalgo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1605 |
Similar Items
-
A new mouse model to study restoration of interleukin-6 (IL-6) expression in a Cre-dependent manner: microglial IL-6 regulation of experimental autoimmune encephalomyelitis
by: Paula Sanchis, et al.
Published: (2020-10-01) -
Interleukin-6 Derived from the Central Nervous System May Influence the Pathogenesis of Experimental Autoimmune Encephalomyelitis in a Cell-Dependent Manner
by: Paula Sanchis, et al.
Published: (2020-01-01) -
Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
by: Martin Sammel, et al.
Published: (2019-07-01) -
Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy
by: Rebekah Robinson, et al.
Published: (2020-07-01) -
Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy
by: Shruti Sharma, et al.
Published: (2021-05-01)